baber/WOPTO huggingface dataset:
Patent AU-2643997-A (AU)
Title: Improvements to crushers with ring-shaped track and roller
Inventor: CHEVALIER PHILIPPE
IPC: B02C15/00
Filed: 1997-04-15
Abstract: PCT No. PCT/FR97/00682 Sec. 371 Date Nov. 2, 1999 Sec. 102(e) Date Nov. 2, 1999 PCT Filed Apr. 15, 1997 PCT Pub. No. WO98/46357 PCT Pub. Date Oct. 22, 1998A grinder having an annular track with a horizontal axis (14), a roller (16) capable of travelling over the track, a mechanism for pressing the roller against the track and means (18) for displacing the material from one edge of the track to the other in such a way that it passes several times beneath the roller before being evacuated. To enhance the efficiency of the grinder and the distribution of mechanical stresses in the roller and the track, the track (14) and the roller (16) are designed in such a way that the gap between them decreases from the edge of the track (14) located on the side for supplying the material to be ground to a distance from this edge at least equal to 80% of the width of the track, and in that this interval then swiftly increases to form a decompression area (19) on the ground material evacuation side.
Patent AU-2715000-A (AU)
Title: Method and construction for connecting together metal and plastic elements
Inventor: TIRAMANI PAOLO M B
IPC: B65D6/28
Filed: 1999-12-28
Abstract: A metal element which includes a surface, a first end portion and an opposite, second, end portion, the first end portion being formed with a plurality of inner cuts designed so as to enable a plurality of pieces each remaining integrally connected to the metal element to at least slightly protrude from the surface, each of the pieces featuring at least one sharp or pointed edge generally pointing towards the opposite, second end portion.
Patent AU-2757084-A (AU)
Title: Catalytic cracking catalyst and process
Inventor: PELLET REGIS JOSEPH
IPC: C10G47/34
Filed: 1984-05-01
Abstract: Catalytic cracking catalysts, the process of their preparation and the process of their use.
Patent AU-2983200-A (AU)
Title: Polyurethane sealant compositions
Inventor: WU ZIYAN
IPC: C03C27/10
Filed: 2000-02-04
Abstract: In one aspect, this invention is a polyurethane sealant composition comprising(1) a urethane prepolymer having an isocyante functionality of at least about 2.0 and a weight average molecular weight of at least about 2,000;(2) a catalytic amount of a tin compound which catalyzes the reaction of isocyanate moieties with water or an active hydrogen containing compound; and(3) a stabilizing amount of an organophosphite which has an alkaryl ligand or both an aliphatic ligand and an aromatic ligand. The prepolymer may further comprises silane functionality or the composition may further comprise a compound or polymer which contains silane moieties and is compatible with the polyurethane prepolymer. The invention is also a method for bonding glass to a substrate which comprises contacting a sealant according to the invention with glass and another substrate with the sealant disposed between the glass and substrate and thereafter allowing the sealant to cure so as to bond the glass to the substrate.
Patent AU-2984692-A (AU)
Title: Process for the manufacture of hydrogen peroxide
IPC: B01J37/02
Filed: 1992-12-03
Abstract: Process for the manufacture of hydrogen peroxide by oxidation of alkylanthraquinones (AO process) in which the stage of hydrogenation of the alkylanthraquinones is carried out in the presence of a catalyst containing palladium supported on alumina granules which have been subjected to a halogenation treatment prior to fixing the palladium.
Patent AU-3008795-A (AU)
Title: Arylthio compounds as antibacterial and antiviral agents
Inventor: DOMAGALA JOHN MICHAEL
IPC: A61K31/63
Filed: 1995-07-11
Abstract: Arylthiol and dithiobisarylamide antibacterial and antiviral agents have the general formula   <IMAGE>   where A is monocyclic or bicyclic aryl which can contain up to 3 heteroatoms selected from O, S, and N, R1 and R2 are substituent groups, X is   <IMAGE>   or SO2NR4Z, Y is H or SZ when n is 1, a single bond when n is 2; R4 and Z can be hydrogen or alkyl.
Patent AU-3026397-A (AU)
Title: Enteric coating, comprising alginic acid, for an oral preparation
Inventor: MARCUSSEN JOERN
IPC: A23L29/00
Filed: 1997-06-06
Abstract: A composition for forming an enteric coating on a tablet, capsule or pellet for oral ingestion includes a liquid mixture of alginic acid particles dispersed in an aqueous solution of a binding agent of locust bean, gum, gelatine, vegetable hydrocolloids and/or animal protein.
Patent AU-3027097-A (AU)
Title: Water continuous dairy base product and process for preparing such product
Inventor: WITH AXEL DE
IPC: A23L27/60
Filed: 1997-05-09
Abstract: PCT No. PCT/EP97/02502 Sec. 371 Date Feb. 3, 1999 Sec. 102(e) Date Feb. 3, 1999 PCT Filed May 9, 1997 PCT Pub. No. WO97/46111 PCT Pub. Date Dec. 11, 1997A water continuous, acidified dairy base product is provided having a dry matter content of 19-40% that contains 7-18% fat and 7-18% protein, the protein contains casein and whey protein and contains at least 50% casein, the protein that is undissolved being 80-100%, that has a pH of 5.9-6.5, a firmness as indicated by the Stevens value at 10 DEG  C. of at least 40 g and a particle size D3.2 as measured by laser diffraction of at most 15 micron. The product can be used for similar purposes as cr+E,gra e+EE me fraiche but it contains more protein and less fat and calories. A process for preparing the product is provided as well.
Patent AU-3414289-A (AU)
Title: Lacrimal secretion stimulant (lss)
Inventor: SCHOENWALD RONALD D
IPC: C07C211/63
Filed: 1989-03-13
Abstract: Ophthalmic compositions useful as tear stimulants when topically applied to the eye for effective treatment of dry eye syndrome.
Patent AU-3704997-A (AU)
Title: Pharmaceutical products for curing and preventing diseases resulting from the damaging of the vascular endothelial cells
Inventor: JEDNAKOVITS ANDREA
IPC: A61K31/41
Filed: 1997-08-06
Abstract: PCT No. PCT/HU97/00044 Sec. 371 Date Dec. 6, 1999 Sec. 102(e) Date Dec. 6, 1999 PCT Filed Aug. 6, 1997 PCT Pub. No. WO98/06400 PCT Pub. Date Feb. 19, 1998The invention relates to a method of treating or preventing illnesses resulting from damaged endothelial cells, wherein the method comprises administering to a patient a product comprising hydroxylamine derivatives of the general formulae (I) with the proviso that in the compounds of general formula (I) when X comprises a -NR3R4 group and Y comprises a hydroxyl group, the X group is condensed with the Y substituent to form an intramolecular ring represented by general formula (Ill)
Patent AU-3763889-A (AU)
Title: Display device
Inventor: PARKER WILLIAM P
IPC: H01J11/18
Filed: 1989-05-09
Abstract: A gas discharge display apparatus in the form of a panel housing a plurality of electroluminescent gas-filled discharge chambers adapted for interactively controlled illumination. The apparatus generally includes an electrically conductive surface underlying the discharge chambers utilized as an electrode for energizing the electroluminescent gas in the chambers. A plasma glow discharge is interactively obtained in the chambers by placing a ground coupled conductive member, such as a human hand, proximal to the chambers opposite the conductive surface.
Patent AU-3766389-A (AU)
Title: Anti-idiotype antibodies to anti-human high molecular weight-melanoma associated antigen
Inventor: FERRONE SOLDANO
IPC: C07K19/00
Filed: 1989-05-17
Abstract: This invention discloses two novel anti-idiotypic antibodies, IMelpg1 and MF11-30 and equivalents thereof, as well as, antibody fragments, peptides or antisera capable of reacting with the idiotope of: (a) murine monoclonal antibody 225.28 and derivatives thereof; or with (b) any monoclonal antibody secreted by hybridomas from any species having the same immunological characteristics as antibody 225.28; or with (c) any polyclonal antisera from any species having the same immunological characteristics as antibody 225.28, capable of reacting with a specific determinant (epitope) of a high molecular weight-melanoma associated antigen are described, together with their preparation and use in the diagnosis, monitoring and treatment of tumors such as melanoma or other diseased cells which express the HMW-MAA epitope recognized by antibody 225.28.
Patent AU-3789795-A (AU)
Title: Electrically balanced connector assembly
Inventor: SIEMON JOHN A
IPC: H01R24/64
Filed: 1995-11-16
Abstract: The electrically balanced connector assembly comprises a printed circuit board including integrally defined capacitive elements designed to compensate for reactive imbalance of electrical components connected to it. A pair of wire termination blocks mounted to a first side of the circuit board are connected by circuitry on the circuit board to a corresponding pair of modular jacks mounted to a second side of the circuit board. The capacitive elements are connected between selected leads of the modular jacks and the wire termination blocks by the circuitry. The circuit board assembly is mounted in a panel yoke which includes a pair of apertures for allowing access to the modular jacks aligned in them. The apertures and circuit board assembly are orientated to allow connecting modular cords to gravity feed into and from the modular jacks. The panel yoke includes a device for snap-lockingly securing the panel yoke to a panel or a wall plate.
Patent AU-3810389-A (AU)
Title: Process for extracting and purifying epidermin
Inventor: WERNER ROLF G
IPC: C07K1/14
Filed: 1989-07-14
Abstract: A process for preparing the polypeptide epidermin with an antibacterial action is described. The process is distinguished by an economic procedure and relatively high epidermin yields.
Patent AU-3876501-A (AU)
Title: Method for the treatment of solid tumors by albumin microparticles incorporating paclitaxel
Inventor: FALCIANI MARCO
IPC: A61K31/337
Filed: 2001-04-20
Abstract: Use of microparticles of Paclitaxel stabilized with albumin for preparing a drug for the treatment of solid tumors sensitive to Paclitaxel, and the drug obtained thereby.
Patent AU-4031093-A (AU)
Title: Dosage inhalator with indicating/interrupting means
Inventor: TROFAST EVA ANN-CHRISTIN
IPC: A61M/
Filed: 1993-05-04
Abstract: PCT No. PCT/SE93/00389 Sec. 371 Date Nov. 14, 1994 Sec. 102(e) Date Nov. 14, 1994 PCT Filed May 4, 1993 PCT Pub. No. WO93/21980 PCT Pub. Date Nov. 11, 1993A dosage inhalator is provided for dispensing to a patient a pharmacologically active compound suspended in a fluid. The dosage inhalator includes a carrier having portions for carrying, by intermittent movement, predetermined and reproducible unit doses of the active compound to a conduit through which it is delivered; a maneuverer for actuating the intermittent movement of the carrier, the maneuverer being movable between first and second predetermined positions by a user of the inhalator; and a member for disrupting the movement of the maneuverer upon exhaustion of the active compound in the storage means. The carrier is actuated by a ratchet mechanism including a spring-biased pawl, the maneuverer includes a lever that is reciprocally displaceable between two distinct positions, and the movement of the ratchet mechanism is limited by the displacement of the lever.
Patent AU-4077095-A (AU)
Title: Analytical method for evaluating flavor stability of fermented alcoholic beverage using electron spin resonance
Inventor: ONO MIYOKO
IPC: G01N33/14
Filed: 1995-12-28
Abstract: Quantitative determination and evaluation of the flavor stability of fermented alcoholic beverages are performed by measuring the changes of the amounts of spin adduct from the formation behavior of active oxygen with passage of time using an ESR apparatus and either determining the value on the time axis of the inflection point of changes of the amounts of spin adduct (defined as the active oxygen formation lag time) or determining the amount of spin adduct after a predetermined time has elapsed after the start of measurement (defined as the active oxygen formation activity). The longer the active oxygen formation lag time or the lower the active oxygen formation activity, the greater the oxygen resistance of the fermented alcoholic beverage, thus making it possible to evaluate that fermented alcoholic beverage as having good flavor stability. In addition, if the formation behavior of active oxygen of semi-finished products in the production process is measured in the same manner, the quality of flavor stability when that semi-finished product has become a finished product can be predicted and evaluated.
Patent AU-4231701-A (AU)
Title: A silencer for an air flow generator
Inventor: HOLM TORBEN MOMME
IPC: A47L9/00
Filed: 2001-03-23
Abstract: The present invention relates to a silencer for reducing the noise emission of an air flow generator comprising a motor (2A) operating a blower (2B), such as an air flow generator in a vacuum cleaner, said silencer comprising a motor housing (1) that delimits a volume which extends at least radially around the air flow generator (2A, 2B), said housing (1) having a wall member extending in a generally axial direction and that is provided with at least one air inlet flow passage (4) and at least one air outlet flow passage (3), wherein at least one of said flow passages includes at least one folded elongated flow channel (3A, 3B) that is integrally formed in the wall member of the motor housing (1). By "folding" or bending the channel (3), a relatively long and compact channel is provided compared to the volume (V) of the housing. This allows for a compact design of the silencer by integrating it into the motor housing. This in turn means that a compact design of the appliance in which the silencer is to be used can be obtained; just as an efficient means of noise reduction is obtainable having the same or even a superior silencing effect compared to the silencers known in the art. Moreover, a relatively simple structure is obtained that is easy and inexpensive to manufacture.
Patent AU-4243300-A (AU)
Title: Fatty acid analogs for diagnosis of coronary artery disease
Inventor: BABICH JOHN W
IPC: C07F13/00
Filed: 2000-04-14
Abstract: Radioimaging agents, which exhibit high uptake and retention in the myocardium are disclosed.
Patent AU-4457789-A (AU)
Title: Improvements in or relating to a method of and/or apparatus for storing produce
Inventor: WOODRUFF RICHARD EARL
IPC: B65D88/74
Filed: 1989-11-10
Abstract: The invention provides a method of, and apparatus for, storing produce under controlled conditions. The invention is advantageously embodied in a transport container (5) so that produce is maintained under controlled conditions during transportation. As with many controlled atmosphere storage or transportation systems, a nitrogen-rich gas and carbon dioxide gas are supplied to the container (5) when required. However, to provide a compact and efficient system, the invention provides that the nitrogen gas be generated from the ambient air surrounding the container using an air splitter (35) while the carbon-dioxide is generated from a store (40) of dry-ice.
Patent AU-4471396-A (AU)
Title: Spray dried erythropoietin
Inventor: MEHTA DEEPAK B
IPC: A61K38/18
Filed: 1995-12-15
Abstract: The present invention provides a method for preparing stable, spray dried rhEPO and the rhEPO powder produced thereby.
Patent AU-4489385-A (AU)
Title: Admixer for two flowing liquids
Inventor: HEPPERLE WILLI
IPC: B01F15/04
Filed: 1985-07-15
Abstract: An admixer for delivering soluble additives to flowing liquids containing a valve with a rotary valve body and a container for receiving the additive in tablet form located in the extension of the valve body. The valve body contains an outer channel guide which can be made to coincide with the valve inlet port and a tubular water guide leading through the interior of the valve body.
Patent AU-4535899-A (AU)
Title: Vaginal active agent delivery procedures and formulations thereof
Inventor: BUNT CRAIG ROBERT
IPC: A61K9/00
Filed: 1999-06-14
Abstract: Intra-vaginal delivery procedures including compositions and units therefor whereby an effective releasable amount of oestradiol 17beta is released to achieve an efficacious effect insofar as oestrus expression is concerned. Preferably a cyclodextrin is utilized to enhance absorption.
Patent AU-4599297-A (AU)
Title: Pressure-sensitive adhesive construction
Inventor: SCHOLZ WILLIAM F
IPC: C09J7/29
Filed: 1997-09-26
Abstract: Prelaminate pressure-sensitive adhesive (PSA) constructions comprise, a first substrate, a coating or release material on a surface of the first substrate, a PSA layer disposed on the coating of release material, and a detackified layer (DL) disposed on a surface of the PSA layer to form a continuous film covering the PSA layer. In first and second embodiments of the construction the DL is activatable to form a tacky layer on top of the PSA layer for lamination with a second substrate. In a third embodiment, the DL includes constituents that when activated migrate into the PSA layer to expose the PSA layer tacky surface for lamination with a second substrate. The prelaminate PSA constructions are completely nonblocking to a minimum 24 hour blocking temperature of about 50° C. at pressure of about 40 kilopascals, thereby allowing such prelaminate PSA construction to be collected, stored, and or transported before being laminated without adhesive interference occurring between continuous layers. The DL in each embodiment is activatable in less than five seconds to provide a tacky layer having a sufficient open tack time to permit lamination at less than about 100° C.
Patent AU-4681401-A (AU)
Title: A small table having a height-adjustable top
Inventor: URBINO DONATO D
IPC: A47B9/16
Filed: 2001-03-23
Abstract: Three legs (16) are articulated in an intermediate position on a centerpiece (12) by means of a respective pin (14); a central vertical guide means (5, 7) is provided between said centerpiece (12) and the top (1) of the table, to permit, with the rotation of the table (1) and of the shaft (5), vertical displacements of the top (1) of the table relative to said centerpiece (12) by means of cords (24) which control a simultaneous variation in the angular position of said legs (16) about the respective hinge pin (14).
Patent AU-4700896-A (AU)
Title: Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
Inventor: FRESKOS JOHN N
IPC: C07D317/62
Filed: 1996-01-18
Abstract: Bis-sulfonamido hydroxyethylamino compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease. The present invention relates to retroviral protease inhibiting compounds of the formula: <CHEM> or a pharmaceutically acceptable salt, prodrug or ester thereof, wherein the variables are as defined herein.
Patent AU-4707285-A (AU)
Title: Process for the single-stage preparation of glycosyl fluorides
Inventor: FRANZ RAIMUND
IPC: C07H5/02
Filed: 1985-09-04
Abstract: A process for the single-stage preparation of glycosyl fluorides by dissolving saccharides in liquid hydrogen fluoride and evaporating the hydrogen fluoride, wherein the resulting glycosyl fluoride is isolated in such a way that, when the evaporation of the hydrogen fluoride is started at a relatively high temperature, in general at -20 DEG  to +20 DEG  C., the evaporation is effected at a high evaporation rate or, when a low evaporation rate is used at the start of the evaporation, a sufficiently low temperature is set, in general -80 DEG  C. to -30 DEG  C.
Patent AU-4714300-A (AU)
Title: Treatment of autoimmune diseases with antagonists which bind to b cell surface markers
Inventor: CURD JOHN G
IPC: A61K47/48
Filed: 2000-05-04
Abstract: The present invention concerns treatment of autoimmune diseases with antagonists which bind to B cell surface markers, such as CD19 or CD20.
Patent AU-4717385-A (AU)
Title: Form-fitting ironing board cover
Inventor: MATTESKY HENRY
IPC: D06F83/00
Filed: 1985-09-09
Abstract: A form-fitting cover for use on an ironing board having nose and heel envelopes formed with a pad sheet attached to the lower surface of an ironing surface sheet whereby the ironing surface sheet is automatically properly positioned when the nose and heel envelopes are fitted onto the ironing board.
Patent AU-4888079-A (AU)
Title: Cephalosporin esters and ethers
Inventor: MONTAVON MARC
IPC: C07D501/36
Filed: 1979-07-12
Abstract: There is presented cephalosporin derivatives which are the readily hydrolysable esters and ethers of compounds of the general formula <IMAGE>  (I)  wherein R represents furyl, thienyl or phenyl optionally substituted by halogen, hydroxy, lower alkoxy or lower alkyl, R1 represents lower alkyl or aminocarbonylmethyl and X represents a group of the formula   <IMAGE>  <IMAGE>  <IMAGE>    in which one of the two symbols R2 and R3 represents hydrogen and the other represents lower alkyl and R4 represents lower alkyl, as well as salts of said esters and ethers and hydrates of said esters, ethers and salts.
Patent AU-4901190-A (AU)
Title: Aqueous crosslinkable silicone dispersion
Inventor: FEDER MICHEL
IPC: C08J3/03
Filed: 1990-02-01
Abstract: An aqueous silicone dispersion crosslinking to an elastomer when water is removed, comprising:
 - 100 parts of an emulsion (A) of the oil-in-water type of an  alpha , omega -dihydroxypolydiorganosiloxane, stabilised with an anionic and/or nonionic surfactant,
 - 0.1 to 20 parts of aminosilane and/or of amidosilane,
 - 0 to 3 parts of a metal cure catalyst,
 - 0 to 250 parts of a nonsiliceous inorganic filler,
 the said emulsion having a pH of between 7 and 13 and a solids content of at least 40 %. 
<??>Use of the emulsions particularly for the production of paints and of silicone elastomer seals, in particular for the building industry.
Patent AU-5127579-A (AU)
Title: 3 beta-amino-2beta-hydroxy steroid
Inventor: BOYD ANDREW CRAIG
IPC: A61K31/575
Filed: 1979-09-27
Abstract: New and pharmacologically useful 3 beta -amino-2 beta -hydroxy steroids of the androstane, oestrane and pregnane series are disclosed having the formula I: <CHEM> and pharmaceutically acceptable non-toxic acid addition salts of these compounds, wherein: (a) R1 is H, alkyl of one to six carbons (preferably lower alkyl, such as methyl), or acyl of one to eighteen carbons;  (b) R2 is H or acyl of one to eighteen carbons;  (c) R3 is H or methyl, preferably methyl; (d) Y is selected from the group consisting of O, acetalized O, H( beta OR4), R5( beta OR4), H( beta COCH3) and H( beta CHOR4CH3);  (e) R4 is H or acyl of one to eighteen carbons; nd (f) R5 is a saturated or unsaturated alkyl group of one to four carbons; as well as pharmaceutically acceptable compositions comprising a pharmaceutically effective amount of a compound of the above formula, and a pharmaceutically effective carrier. The novel compounds have anti-arrhythmic properties, have no or minimal and transient haemodynamic effects, have no local anaesthetic properties and do not cause CNS stimulation. The compounds also have prophylactic effect and decrease infarctsize.
Patent AU-5183386-A (AU)
Title: Inert synthetic polymeric carrier combined with bioactive molecule and targetting moieties via peptide spacers
IPC: A61K47/48
Filed: 1986-01-03
Abstract: A polymeric drug comprising an inert synthetic polymeric carrier combined through aminoacid or peptide spacers with a bioactive molecule, a targeting moiety, and an optional cross-linkage, comprises:(a) 5.0 to 99.7 mol % of units derived from N-(2-hydroxypropyl) methacrylamide,(b) 0.2 to 20.0 mol % of units derived from an N-methacryloylated peptide, the peptide groups being bound to a bioactive moiety,(c) 0.1 to 94.8 mol % of units derived from N-methacrylamide, N-methacrylic acid or an N-meth- ecryloylated aminoacid or peptide, to which are bound a determinant capable of interacting with specific receptors on cell surfaces,(d) optionally, 0 to 5 mol % of units derived from an N-methacryloylated peptide, the peptide groups being bound to a linking group which is similarly attached to a similar peptide group attached to another polymer chain, and(e) optionally, as a bioassay label, Q to 2 mol % of units derived from N-methacryloylated tyrosinamide.